Nana Muazin

Tariff Turbulence: How Proposed Levies on Generic Medicines Could Reshape the Pharmaceutical Landscape

• Chemotherapy and Targeted Therapy

Tariff Turbulence: How Proposed Levies on Generic Medicines Could Reshape the Pharmaceutical Landscape

Nana Muazin July 22, 2026

The Trump administration’s aggressive use of trade policy as a lever for domestic industrial policy has entered...

Read More Read more about Tariff Turbulence: How Proposed Levies on Generic Medicines Could Reshape the Pharmaceutical Landscape

Unveiling the Epigenetic Switch: How GATA6 Loss Fuels Colorectal Cancer’s Deadly Spread to the Liver

• Medical Research and Clinical Trials

Unveiling the Epigenetic Switch: How GATA6 Loss Fuels Colorectal Cancer’s Deadly Spread to the Liver

Nana Muazin July 22, 2026

New research from Weill Cornell Medicine and MIT identifies a critical epigenetic mechanism driving colorectal cancer metastasis,...

Read More Read more about Unveiling the Epigenetic Switch: How GATA6 Loss Fuels Colorectal Cancer’s Deadly Spread to the Liver

The Economics of Constraint: How Most-Favored-Nation Pricing is Rewriting the Generic Drug Playbook

• Treatment Innovations

The Economics of Constraint: How Most-Favored-Nation Pricing is Rewriting the Generic Drug Playbook

Nana Muazin July 21, 2026

The pharmaceutical landscape in the United States is undergoing a profound structural metamorphosis. As federal regulators and...

Read More Read more about The Economics of Constraint: How Most-Favored-Nation Pricing is Rewriting the Generic Drug Playbook

Inflammasome sets sights on Phase III amid eye disease drug’s mid-stage score

• Medical Research and Clinical Trials

Inflammasome sets sights on Phase III amid eye disease drug’s mid-stage score

Nana Muazin July 21, 2026

Boston, MA – In a significant development for the treatment of geographic atrophy (GA), a leading cause...

Read More Read more about Inflammasome sets sights on Phase III amid eye disease drug’s mid-stage score

Advancing Post-Operative Care: BRIJ Medical Launches Innovative BRIJ-SEAL Incision Management System

• Treatment Innovations

Advancing Post-Operative Care: BRIJ Medical Launches Innovative BRIJ-SEAL Incision Management System

Nana Muazin July 21, 2026

In the evolving landscape of surgical technology, the focus has increasingly shifted toward optimizing patient recovery and...

Read More Read more about Advancing Post-Operative Care: BRIJ Medical Launches Innovative BRIJ-SEAL Incision Management System

The GLP-1 Dilemma: Balancing Weight Loss Medications and Body Contouring Surgery

• Breast Cancer Surgery and Reconstruction

The GLP-1 Dilemma: Balancing Weight Loss Medications and Body Contouring Surgery

Nana Muazin July 20, 2026

As the popularity of GLP-1 receptor agonists (GLP1ra)—such as semaglutide and tirzepatide—continues to skyrocket, a complex medical...

Read More Read more about The GLP-1 Dilemma: Balancing Weight Loss Medications and Body Contouring Surgery

World Health Assembly Mobilizes Global Action on TB, Rare Diseases, and the Crisis of Information Integrity

• Breast Cancer Prevention and Lifestyle

World Health Assembly Mobilizes Global Action on TB, Rare Diseases, and the Crisis of Information Integrity

Nana Muazin July 20, 2026

At the most recent session of the World Health Assembly, global health leaders convened to address a...

Read More Read more about World Health Assembly Mobilizes Global Action on TB, Rare Diseases, and the Crisis of Information Integrity

Race Against Time: CEPI Fast-Tracks Three Vaccine Candidates to Combat Bundibugyo Ebolavirus

• Chemotherapy and Targeted Therapy

Race Against Time: CEPI Fast-Tracks Three Vaccine Candidates to Combat Bundibugyo Ebolavirus

Nana Muazin July 20, 2026

In an urgent response to the burgeoning Bundibugyo ebolavirus (BDBV) outbreak in the Democratic Republic of the...

Read More Read more about Race Against Time: CEPI Fast-Tracks Three Vaccine Candidates to Combat Bundibugyo Ebolavirus

ASCO 2026: A Paradigm Shift in Oncology—From Genomic Precision to AI-Driven Personalization

• Patient Advocacy and Support

ASCO 2026: A Paradigm Shift in Oncology—From Genomic Precision to AI-Driven Personalization

Nana Muazin July 19, 2026

The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, held in its traditional hub of Chicago,...

Read More Read more about ASCO 2026: A Paradigm Shift in Oncology—From Genomic Precision to AI-Driven Personalization

Finding Strength in Community: A Survivor’s Journey Through Triple-Positive Breast Cancer

• Survivorship and Post-Treatment

Finding Strength in Community: A Survivor’s Journey Through Triple-Positive Breast Cancer

Nana Muazin July 19, 2026

By Staff Writer June 02, 2026 For Alexis Fish, the month of June carries a dual significance....

Read More Read more about Finding Strength in Community: A Survivor’s Journey Through Triple-Positive Breast Cancer